NumFin

Starpharma Holdings Limited

Simbol: SPHRF

PNK

0.0774

USD

Tržna cena danes

  • -3.8414

    Razmerje P/E

  • -0.0396

    Razmerje PEG

  • 31.89M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Starpharma Holdings Limited (SPHRF) Finančni izkazi

Download
LetniČetrtletno
LinearnoLog
Na grafu so prikazane privzete številke v dinamiki za Starpharma Holdings Limited (SPHRF). Prihodki podjetja prikazujejo povprečje 1.612 M, ki je 67.285 % gowth. Povprečni bruto dobiček za celotno obdobje je 1.365 M, ki je 67.252 %. Povprečno razmerje bruto dobička je 0.772 %. Rast čistega dobička za lanskoletno poslovanje podjetja je -0.032 %, kar je enako -1.532 % % v povprečju v celotni zgodovini podjetja.,

LetniČetrtletno
10Y20Y30Y40Y

Bilanca stanja

Če pogledamo fiskalno pot podjetja Starpharma Holdings Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini -0.213. Na področju kratkoročnih sredstev SPHRF znaša 47.122 v valuti poročanja. Velik del teh sredstev, natančneje 35.18, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za -0.295%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 0, če obstajajo, v valuti poročanja. To pomeni razliko v višini 0.000% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 2.75 v valuti poročanja. Ta številka pomeni medletno spremembo v višini 0.010%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 34.815 v valuti poročanja. Letna sprememba tega vidika je -0.281%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 8.235, zaloge na 2.77, dobro ime pa na 0, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

balance-sheet.row.cash-and-short-term-investments

149.3635.249.960.5
30.1
41.3
51.3
61.2
46
30.8
24
33.8
42.8
18.9
22.9
11.6
7.5
10.1
14.3
8.2
15.7
7.9
17.4
25.4
28.1
0
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

14.748.27.88.4
6.1
6.1
6.1
4.2
4.1
4
4.4
5.3
1.9
0.9
1.3
1.5
1.8
1.3
2.8
0
0.5
0.4
0.3
0.3
0.7
0
0

balance-sheet.row.inventory

11.012.82.81.7
0.5
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0

balance-sheet.row.other-current-assets

14.820.90.10.1
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.1
0
0.1
0
0
0

balance-sheet.row.total-current-assets

186.8347.160.770.8
36.7
47.8
57.5
65.7
50.3
35.1
28.6
39.3
44.9
19.9
24.2
13.2
9.3
11.4
17.1
8.4
16.2
8.5
17.8
25.8
28.9
0
0

balance-sheet.row.property-plant-equipment-net

19.2955.52.5
2.4
1.1
1.1
0.9
0.7
0.9
0.5
0.4
0.4
0.3
0.2
0.4
0.8
1.1
1.4
1.2
1.6
2
0.9
0.2
0.1
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
2
1.9
1.6
1.6
1.5
1.4
1.7
1.8
1.5
1.8
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
6.1
6.5
6.2
7.2
7.5
8.2
11.4
13.4
13.1
16
4.1
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
8.1
8.4
7.8
8.8
9
9.6
13.1
15.2
14.6
17.8
4.1
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
2.4
2.9
0.7
0.3
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

-4.96-5-5.5-2.5
-2.4
-1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0

balance-sheet.row.total-non-current-assets

19.2955.52.5
2.4
1.1
1.1
0.9
8.8
9.3
8.3
9.2
9.4
9.9
13.3
15.7
15.4
19
7.9
4.1
2.2
2.3
1
0.2
0.1
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

206.1352.166.273.2
39.1
48.9
58.5
66.6
59
44.4
36.9
48.5
54.3
29.8
37.6
28.8
24.7
30.4
25
12.5
18.5
10.7
18.9
26
29.1
0
0

balance-sheet.row.account-payables

23.356.66.86.7
4.4
4.1
3
4
8.2
5.5
2.6
1.2
4.2
0.9
1.3
1.8
1.6
1.9
1.9
1.6
0.4
0.7
1.2
1
0.2
0
0

balance-sheet.row.short-term-debt

6.245.50.70.7
0.6
0
0
0
0
0
0
0
0
0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

14.962.87.50.5
1
0
0
0
0
0
0
0.1
0.1
0
0
0.2
0.3
0.3
0.3
0.1
0.1
0.2
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

8.752.32.32.6
1.3
1.9
1.7
1.5
1.3
1.2
1.2
1.1
0.8
0.7
0.5
0.3
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.1
0
0
0

balance-sheet.row.total-non-current-liabilities

15.22.87.60.5
1.1
0
0.1
0.1
0
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.6
1.4
0.7
0.2
0.1
0.2
0
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

13.172.84.21.2
1.6
0
0
0.1
0
0
0.1
0.1
0.1
0.1
0.2
0.1
0.4
0.3
0.5
0.1
0.2
0.3
0
0
0
0
0

balance-sheet.row.total-liab

54.0217.317.810.9
7.8
6.5
5.2
5.6
9.6
6.8
3.9
2.6
5.6
2.1
2.7
3.3
4.3
4.7
3.7
2.5
0.9
1.5
1.6
1.1
0.2
0
0

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

962.81240.7240.7240.6
193.7
193.6
193.6
193.5
193.5
160.9
140.3
140.1
139.2
105.4
101.8
85.6
78.7
76.2
65.4
46.8
46.8
33
33
33
33.1
0
0

balance-sheet.row.retained-earnings

-923.22-234.2-218.6-202.4
-182.7
-168
-153.7
-143.5
-153.9
-131.2
-112.3
-97.6
-92.4
-78.7
-69.8
-63.4
-59.3
-51.8
-44.6
-36.8
-29.2
-23.7
-16
-8.1
-4.2
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

112.5228.326.324.1
20.3
16.8
13.4
10.9
9.8
7.9
4.9
3.5
1.9
1
2.9
3.3
1
1.3
0.5
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-stockholders-equity

152.1134.848.462.3
31.3
42.4
53.3
61
49.4
37.6
33
46
48.7
27.7
34.8
25.5
20.4
25.7
21.3
10
17.6
9.2
17
24.9
28.9
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

206.1352.166.273.2
39.1
48.9
58.5
66.6
59
44.4
36.9
48.5
54.3
29.8
37.6
28.8
24.7
30.4
25
12.5
18.5
10.7
18.9
26
29.1
0
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0
0
0
0

balance-sheet.row.total-equity

152.1134.848.462.3
31.3
42.4
53.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

206.13---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
2.4
2.9
0.7
0.3
0
0
0
0
0

balance-sheet.row.total-debt

21.28.38.21.2
1.6
0
0
0.1
0
0
0.1
0.1
0.1
0.1
0.2
0.3
0.4
0.3
0.5
0.1
0.2
0.3
0
0
0
0
0

balance-sheet.row.net-debt

-128.16-26.9-41.7-59.3
-28.5
-41.2
-51.3
-61.1
-46
-30.8
-24
-33.7
-42.7
-18.9
-22.7
-11.3
-7.1
-9.7
-13.8
-8
-15.5
-7.6
-17.4
-25.4
-28.1
0
0

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Starpharma Holdings Limited opazno spremenil prosti denarni tok, ki se je spremenil v -0.011. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko 0.019 v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini -610000.000 v valuti poročanja. To je premik za -0.270 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 1.19, 0 in -0.69, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo 0 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane -0.69, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

-12.59-15.6-16.2-19.7
-14.7
-14.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.depreciation-and-amortization

1.721.21.10.9
0.9
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

-2.01-5.7-4.6-6.3
-5.9
-3.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

2.062.12.23.7
3.6
3.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-0.49-1-0.1-0.6
-0.3
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-receivables

-1.26-1.30.6-2.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0.050.1-1.1-1.2
-0.1
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-0.10.32.9
-0.4
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0.710.200.1
0.2
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

2.855.64.47.1
5.6
2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

-9.53000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.25-0.6-0.8-0.2
-0.1
-0.3
-0.4
-0.6
-0.1
-0.7
-0.3
-0.2
-0.1
-0.1
0
0
0
-0.2
-0.5
-0.4
-0.2
-1.6
-0.9
-0.2

cash-flows.row.acquisitions-net

0000
0
0
0
33.3
0
0
0
0
0
0
0
0
0
-0.1
0
-0.3
0
-0.9
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1.5
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0.01000
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0.3
0
0
0
0

cash-flows.row.other-investing-activites

0.01000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-0.23-0.6-0.8-0.2
-0.1
-0.3
-0.4
32.7
0
-0.7
-0.3
-0.2
-0.1
-0.1
0
0
0
-0.3
-0.4
-1.6
-0.2
-2.5
-0.9
-0.2

cash-flows.row.debt-repayment

-4.78-0.7-4-0.6
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

00048.9
0
0
0
0
33.9
21.4
0.2
0.9
35.2
3.6
15.7
7.2
3.8
0
15
0
14.5
0
0.2
22.9

cash-flows.row.common-stock-repurchased

000-1.9
0
0
0
0
-1.3
-0.9
0
0
-1.4
0
-0.6
-0.2
-0.3
0
-0.8
0
-0.7
0
0
-1.6

cash-flows.row.dividends-paid

000-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-5.5-0.77.20.6
-0.6
0
0
0
0
0
0
-0.1
-0.1
-0.1
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
-0.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-8.25-0.73.246.3
-0.6
0
0
0
32.6
20.5
0.2
0.8
33.7
3.5
15
6.8
3.4
-0.1
14
-0.1
13.7
-0.1
0.2
20.8

cash-flows.row.effect-of-forex-changes-on-cash

0.10.10.2-0.8
0.3
0.6
0.7
-0.5
0.3
0.6
0
0.2
0.1
-0.8
-0.1
1.4
-0.6
-0.4
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-61.9-14.7-10.630.4
-11.2
-10.1
-9.9
15.2
15.1
6.8
-9.8
-9
23.9
-3.9
11.3
4.1
-2.6
-4.2
6.1
-7.5
7.8
-9.5
-8
18.2

cash-flows.row.cash-at-end-of-period

61.3635.249.960.5
30.1
41.3
51.3
61.2
46
30.8
24
33.8
42.8
18.9
22.9
11.6
7.5
10.1
14.3
8.2
15.7
7.9
17.4
25.4

cash-flows.row.cash-at-beginning-of-period

123.2649.960.530.1
41.3
51.3
61.2
46
30.8
24
33.8
42.8
18.9
22.9
11.6
7.5
10.1
14.3
8.2
15.7
7.9
17.4
25.4
7.2

cash-flows.row.operating-cash-flow

-9.53-13.5-13.2-14.8
-10.8
-10.3
-10.2
-17
-17.8
-13.6
-9.8
-9.8
-9.8
-6.5
-3.6
-4
-5.4
-3.4
-7.5
-5.8
-5.8
0
-7.3
-2.5

cash-flows.row.capital-expenditure

-0.25-0.6-0.8-0.2
-0.1
-0.3
-0.4
-0.6
-0.1
-0.7
-0.3
-0.2
-0.1
-0.1
0
0
0
-0.2
-0.5
-0.4
-0.2
-1.6
-0.9
-0.2

cash-flows.row.free-cash-flow

-9.78-14.2-14-15.1
-10.9
-10.7
-10.6
-17.6
-17.9
-14.3
-10.1
-10
-9.9
-6.6
-3.7
-4.1
-5.4
-3.6
-8
-6.2
-6
-1.6
-8.2
-2.6

Vrstica izkaza poslovnega izida

Prihodki Starpharma Holdings Limited so se v primerjavi s prejšnjim obdobjem spremenili za -0.372%. Bruto dobiček podjetja SPHRF znaša 1.22. Odhodki iz poslovanja podjetja so 25.9 in so se v primerjavi s prejšnjim letom spremenili za 31.999%. Odhodki za amortizacijo znašajo 1.19, kar je 0.107% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 25.9, ki kaže 31.999% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja -0.393% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so -24.67, ki kažejo 0.393% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je -0.032%. Čisti prihodki v zadnjem letu so znašali -15.64.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

income-statement-row.row.total-revenue

14.362.94.71.8
6
1.7
3.8
3
3.8
0.8
0.3
0
0.9
1.1
1.4
2
1.4
0.9
0
2
1.4
1.5
0.4
0
0
0
0

income-statement-row.row.cost-of-revenue

7.481.72.80.8
0.9
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

6.881.21.91
5.1
1.4
3.8
3
3.8
0.8
0.3
0
0.9
1.1
1.4
2
1.4
0.9
0
2
1.4
1.5
0.4
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

25.98---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

3.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

6.37---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.10.31.3
0.6
0
0.1
0
0.1
0
0
0.8
0.2
1.2
3.8
7.7
8.2
8.1
6.4
1.4
0.7
0
0.2
0.5
0
0
0

income-statement-row.row.operating-expenses

27.525.919.623.4
21.8
17
15.6
19.8
28.2
21.9
17
8.7
17.7
13.7
14
16.1
18
17.3
13.9
10.4
7.3
8.8
9.3
5.6
0
0
0

income-statement-row.row.cost-and-expenses

34.9827.622.424.2
22.7
17.3
15.6
19.8
28.2
21.9
17
8.7
17.7
13.7
14
16.1
18
17.3
13.9
10.4
7.3
8.8
9.3
5.6
0
0
0

income-statement-row.row.interest-income

1.581.30.20.4
0.5
1.1
1.1
0.7
0.7
0.9
1
1.6
1.8
1
0.7
0.1
0.3
0.6
0.6
0.6
0.6
0.6
0.9
1.1
0
0
0

income-statement-row.row.interest-expense

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

6.37---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

1.621.40.31.3
0.6
0
0.1
0
0.1
0
0
0.8
0.2
1.2
3.8
7.7
8.1
7.9
5.8
0.8
0.4
-0.2
0.2
0.5
1.8
1.2
1.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.10.31.3
0.6
0
0.1
0
0.1
0
0
0.8
0.2
1.2
3.8
7.7
8.2
8.1
6.4
1.4
0.7
0
0.2
0.5
0
0
0

income-statement-row.row.total-operating-expenses

1.621.40.31.3
0.6
0
0.1
0
0.1
0
0
0.8
0.2
1.2
3.8
7.7
8.1
7.9
5.8
0.8
0.4
-0.2
0.2
0.5
1.8
1.2
1.3

income-statement-row.row.interest-expense

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

1.321.21.10.9
0.9
0.3
0.3
0.9
0.9
1.2
1.1
1.1
1.1
1.5
1.7
2
2.1
2
1
0.7
0.6
0.6
0.2
0.1
0
0
0

income-statement-row.row.ebitda-caps

-19.31---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-20.63-24.7-17.7-22.4
-16.7
-15.6
-11.7
-15.2
-22.7
-18.9
-14.6
-5.2
-13.7
-8.9
-6.4
-4.3
-10.2
-10
-7.5
-7.6
-5.5
-7.5
-9.3
-5.6
-3.5
-2.3
-2.5

income-statement-row.row.income-before-tax

-19.01-23.3-16.2-19.7
-14.7
-14.3
-10.3
-15.2
-22.7
-18.9
-14.6
-5.2
-13.7
-8.9
-6.4
-4.3
-8.2
-8
-7.5
-7.6
-5.5
-7.5
-8
-3.9
-1.8
-1.2
-1.3

income-statement-row.row.income-tax-expense

-6.42-7.6-1.3-1.3
-1.4
-1.4
-1.4
-23.4
0.1
0
0
0.9
0.2
1.2
0
-0.2
-0.7
-0.7
5.8
-7.6
-5.5
-7.5
-8
-3.9
-1.8
-1.2
-1.3

income-statement-row.row.net-income

-12.59-15.6-16.2-19.7
-14.7
-14.3
-10.3
8.2
-22.7
-18.9
-14.6
-5.2
-13.7
-8.9
-6.4
-4.1
-7.5
-7.2
-7.5
-7.6
-5.5
-0.2
0.1
-3.9
-1.8
-1.2
-1.3
Podobne delnice
Morda vas zanima tudi:
SRNE
Sorrento Therapeutics, Inc..
0.0135 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.87 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.02684 USD
NASDAQ
GUBRA.CO
Gubra A/S.
338 DKK
CPH
T5O.DE
CytoTools AG.
0.408 EUR
XETRA
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.55 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Pogosto zastavljeno vprašanje

Kaj je Starpharma Holdings Limited (SPHRF) skupna sredstva?

Starpharma Holdings Limited (SPHRF) skupna sredstva so 52086000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 11209500.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.479.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.024.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.877.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -1.436.

Kaj je Starpharma Holdings Limited (SPHRF) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -15638000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 8272000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 25895500.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 32131000.000.